A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis - Join Clinical Trial NCTNCT07012395
How to Join This Clinical Trial - NCTNCT07012395
Learn how to participate in this PHASE2 trial studying an investigational therapy for Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative. This study is currently enrolling participants.
Am I Eligible for This Clinical Trial?
This clinical research study is looking for participants with Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.
- Condition Being Studied
- Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative
- Treatment Being Tested
- Investigational treatment
- Study Phase
- PHASE2 - Safety and effectiveness study
- Enrollment Status
- Currently enrolling participants
- Study Identifier
- NCTNCT07012395 - ClinicalTrials.gov Identifier
- Sponsored By
- Study sponsor
What to Expect as a Participant
Participating in this clinical trial involves:
- Initial screening to determine eligibility
- Regular study visits and health assessments
- Receiving the study treatment or placebo
- Medical monitoring and follow-up care
- Contributing to medical research that may help others
- Potential access to new treatments before they're widely available
Clinical Trial Benefits and Compensation
Participants in this clinical research study may receive:
- Close medical monitoring by healthcare professionals
- Access to potential new treatments
- Compensation for time and travel (varies by study)
- No-cost study-related medical care
- The opportunity to help advance medical knowledge
Where Is This Clinical Trial Located?
This study is enrolling participants at 11 locations. Find a study site near you:
Clinical Research Site
Lancaster, California 93534 - United States
Status: RECRUITING
Clinical Research Site
Kissimmee, Florida 34741 - United States
Status: RECRUITING
Clinical Research Site
Winston-Salem, North Carolina 27103 - United States
Status: RECRUITING
Clinical Research Site
Providence, Rhode Island 02904 - United States
Status: RECRUITING
Clinical Research Site
Kingsport, Tennessee 37663 - United States
Status: RECRUITING
Clinical Research Site
Cedar Park, Texas 78613 - United States
Status: RECRUITING
Clinical Research Site
Garland, Texas 75246 - United States
Status: RECRUITING
Clinical Research Site
San Antonio, Texas 78229 - United States
Status: RECRUITING
Clinical Research Site
Southlake, Texas 76092 - United States
Status: RECRUITING
Clinical Research Site
Webster, Texas 77598 - United States
Status: RECRUITING
And 1 more locations available. Contact us to find the nearest participating site.
How to Enroll in This Study
To learn more about participating in this PHASE2 clinical trial for Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis, Colitis, Ulcerative:
- Review the eligibility criteria with your healthcare provider
- Contact the study team for a pre-screening interview
- Schedule an in-person screening visit if eligible
- Review and sign the informed consent form
- Begin participation in the clinical trial
Why Choose Quri.ai Study Finder
Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:
- Discover clinical trials before competitors
- Access exclusive contact information
- Track sponsor pipelines and opportunities
- Connect with decision makers directly
- Win more business partnerships